Eugia Pharma Company Profile

✉ Email this page to a colleague

EUGIA PHARMA has one hundred and sixty-eight approved drugs.

There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.

There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and thirty-seven supplementary protection certificates in eighteen countries.

International Patents:	10
US Patents:	1
Tradenames:	142
Ingredients:	134
NDAs:	168
Patent Litigation for Eugia Pharma:	See patent lawsuits for Eugia Pharma

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eugia Pharma	METHYLPREDNISOLONE SODIUM SUCCINATE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	207667-002	Dec 15, 2015		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Eugia Pharma	DEXMEDETOMIDINE HYDROCHLORIDE	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	205867-001	Mar 17, 2016	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Eugia Pharma	TIMOLOL MALEATE	timolol maleate	SOLUTION, GEL FORMING/DROPS;OPHTHALMIC	213540-001	Mar 23, 2023	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Eugia Pharma	TESTOSTERONE CYPIONATE	testosterone cypionate	INJECTABLE;INJECTION	211817-001	Oct 20, 2023	AO	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Eugia Pharma	SUMATRIPTAN SUCCINATE	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	202758-001	Apr 23, 2013	AP	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
Eugia Pharma	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	213278-002	Nov 2, 2020	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Brazil	112016026140	⤷ Try a Trial
Japan	2017514924	⤷ Try a Trial
Russian Federation	2016147362	⤷ Try a Trial
South Korea	20170008252	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2015171460	⤷ Try a Trial
Canada	2948148	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1411918	C20120014 00064	Estonia	⤷ Try a Trial	PRODUCT NAME: MOZOBIL - PLERIXAFOR;REG NO/DATE: C(2009)6238 31.07.2009
0316704	C300045	Netherlands	⤷ Try a Trial	PRODUCT NAME: CAPECITABINE,DESGEWENST IN DE VORM VAN EEN SOLVAAT; NATL REGISTRATION NO/DATE: EU/1/00/163/001-002 20010202; FIRST REGISTRATION: CH 54657 19980610
1746976	17C1027	France	⤷ Try a Trial	PRODUCT NAME: SEL DE SUCROSOFATE D'IRINOTECAN; REGISTRATION NO/DATE: EU/1/16/1130 20161018
0817775	C300214	Netherlands	⤷ Try a Trial	PRODUCT NAME: ERLOTINIB, DESGEWENST IN DE; REGISTRATION NO/DATE: 57266 01,..02,..03EU/1/05/311/001...003 20050321
2340828	LUC00195	Luxembourg	⤷ Try a Trial	PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE DE SEL DE SODIUM SACUBITRIL VALSARTAN, C'EST-A-DIRE (((S)-N-VALERYL-N-((2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL)-METHYL)-VALINE) ((2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-ESTER ETHYLIQUE D'ACIDE PENTANOIQUE))NA3 X H2O, DANS LEQUEL X EST 0 A 3; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123
1411900	SPC/GB11/015	United Kingdom	⤷ Try a Trial	PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.